Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Fragile X Syndrome
Interventions
DRUG

AFQ056

DRUG

Placebo

Trial Locations (38)

1200

Novartis Investigative Site, Brussels

2145

Novartis Investigative Site, Westmead

2600

Novartis Investigative Site, Glostrup Municipality

3000

Novartis Investigative Site, Leuven

3052

Novartis Investigative Site, Parkville

8091

Novartis Investigative Site, Zurich

10314

Novartis Investigative Site, Staten Island

16147

Novartis Investigative Site, Genova

16374

Novartis Investigative Site, Spånga

29009

Novartis Investigative Site, Málaga

30033

Novartis Investigative Site, Decatur

34093

Novartis Investigative Site, Istanbul

35128

Novartis Investigative Site, Padua

37212

Novartis Investigative Site, Nashville

52621

Novartis Investigative Site, Ramat Gan

55131

Novartis Investigative Site, Mainz

60612

Novartis Investigative Site, Chicago

69677

Novartis Investigative Site, Bron

72076

Novartis Investigative Site, Tübingen

75013

Novartis Investigative Site, Paris

77030

Novartis Investigative Site, Houston

80639

Novartis Investigative Site, München

81241

Novartis Investigative Site, München

95817

Novartis Investigative Site, Sacramento

97070

Novartis Investigative Site, Würzburg

02115

Novartis Investigative Site, Boston

68198-5575

Novartis Investigative Site, Omaha

T6G 2E1

Novartis Investigative Site, Edmonton

Unknown

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Semarang

Novartis Investigative Site, Lausanne

H3T1C5

Novartis Investigative Site, Montreal

01307

Novartis Investigative Site, Dresden

00168

Novartis Investigative Site, Roma

3015 CE

Novartis Investigative Site, Rotterdam

08208

Novartis Investigative Site, Sabadell

08190

Novartis Investigative Site, Sant Cugat del Vallès

EH10 5HF

Novartis Investigative Site, Edinburgh

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY